TBC1D13
gene geneOn this page
Also known as FLJ10743
Summary
TBC1D13 (TBC1 domain family member 13, HGNC:25571) is a protein-coding gene on chromosome 9q34.11, encoding TBC1 domain family member 13 (Q9NVG8). Acts as a GTPase-activating protein for RAB35.
Predicted to enable GTPase activator activity. Predicted to be involved in intracellular protein transport. Predicted to be located in cytosol and membrane. Predicted to be active in cytoplasm.
Source: NCBI Gene 54662 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_018201
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25571 |
| Approved symbol | TBC1D13 |
| Name | TBC1 domain family member 13 |
| Location | 9q34.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10743 |
| Ensembl gene | ENSG00000107021 |
| Ensembl biotype | protein_coding |
| OMIM | 616218 |
| Entrez | 54662 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000223865, ENST00000372648, ENST00000466056, ENST00000475097, ENST00000858130, ENST00000858131, ENST00000946366, ENST00000946367
RefSeq mRNA: 2 — MANE Select: NM_018201
NM_001286772, NM_018201
CCDS: CCDS6911, CCDS69677
Canonical transcript exons
ENST00000372648 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000927257 | 128805859 | 128806019 |
| ENSE00000927258 | 128806254 | 128806311 |
| ENSE00001110194 | 128787253 | 128787376 |
| ENSE00001110196 | 128807814 | 128810430 |
| ENSE00001143555 | 128803956 | 128804119 |
| ENSE00001143562 | 128803250 | 128803460 |
| ENSE00003459488 | 128788334 | 128788407 |
| ENSE00003559371 | 128791380 | 128791441 |
| ENSE00003588316 | 128791594 | 128791693 |
| ENSE00003595202 | 128790735 | 128790775 |
| ENSE00003609533 | 128792492 | 128792574 |
| ENSE00003656713 | 128797055 | 128797214 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 90.13.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.1853 / max 85.6499, expressed in 1792 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 98836 | 11.2159 | 1783 |
| 98837 | 0.7065 | 437 |
| 98835 | 0.2560 | 94 |
| 98838 | 0.0070 | 4 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| anterior cingulate cortex | UBERON:0009835 | 90.13 | gold quality |
| cingulate cortex | UBERON:0003027 | 90.07 | gold quality |
| right frontal lobe | UBERON:0002810 | 89.61 | gold quality |
| amygdala | UBERON:0001876 | 89.59 | gold quality |
| apex of heart | UBERON:0002098 | 89.10 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 89.07 | gold quality |
| islet of Langerhans | UBERON:0000006 | 88.63 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.18 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 87.67 | gold quality |
| nucleus accumbens | UBERON:0001882 | 87.41 | gold quality |
| putamen | UBERON:0001874 | 87.35 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.96 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 86.96 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 86.93 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.89 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.88 | gold quality |
| hypothalamus | UBERON:0001898 | 86.85 | gold quality |
| neocortex | UBERON:0001950 | 86.79 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.72 | gold quality |
| caudate nucleus | UBERON:0001873 | 86.65 | gold quality |
| frontal cortex | UBERON:0001870 | 86.58 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.52 | gold quality |
| gastrocnemius | UBERON:0001388 | 86.39 | gold quality |
| adrenal cortex | UBERON:0001235 | 86.35 | gold quality |
| kidney | UBERON:0002113 | 86.34 | gold quality |
| stromal cell of endometrium | CL:0002255 | 86.24 | gold quality |
| muscle of leg | UBERON:0001383 | 86.07 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.01 | gold quality |
| granulocyte | CL:0000094 | 85.99 | gold quality |
| cortex of kidney | UBERON:0001225 | 85.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.59 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
110 targeting TBC1D13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-2116-3P | 99.74 | 64.32 | 889 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tbc1d13 | ENSMUSG00000039678 |
| rattus_norvegicus | Tbc1d13 | ENSRNOG00000015970 |
Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), GRTP1 (ENSG00000139835), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), SGSM1 (ENSG00000167037), TBC1D21 (ENSG00000167139), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3K (ENSG00000273513), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512), TBC1D3 (ENSG00000274611)
Protein
Protein identifiers
TBC1 domain family member 13 — Q9NVG8 (reviewed: Q9NVG8)
All UniProt accessions (2): Q9NVG8, A0A024R8C8
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a GTPase-activating protein for RAB35. Together with RAB35 may be involved in regulation of insulin-induced glucose transporter SLC2A4/GLUT4 translocation to the plasma membrane in adipocytes.
Subunit / interactions. Interacts with RAB1A and RAB10; in a GTP-dependent manner.
Subcellular location. Membrane. Cytoplasm.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NVG8-1 | 1 | yes |
| Q9NVG8-2 | 2 | |
| Q9NVG8-3 | 3 |
RefSeq proteins (2): NP_001273701, NP_060671* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000195 | Rab-GAP-TBC_dom | Domain |
| IPR035969 | Rab-GAP_TBC_sf | Homologous_superfamily |
Pfam: PF00566
UniProt features (8 total): sequence conflict 3, splice variant 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NVG8-F1 | 88.57 | 0.69 |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-8854214 | TBC/RABGAPs |
| R-HSA-199991 | Membrane Trafficking |
| R-HSA-5653656 | Vesicle-mediated transport |
| R-HSA-9007101 | Rab regulation of trafficking |
MSigDB gene sets: 178 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOMF_GTPASE_BINDING, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, PATIL_LIVER_CANCER, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, GOBP_CILIUM_ORGANIZATION, RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, GOBP_ORGANELLE_ASSEMBLY, LIAO_METASTASIS, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, DOUGLAS_BMI1_TARGETS_DN, GOBP_REGULATION_OF_CILIUM_ASSEMBLY
GO Biological Process (1): intracellular protein transport (GO:0006886)
GO Molecular Function (3): GTPase activator activity (GO:0005096), small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (3): cytoplasm (GO:0005737), cytosol (GO:0005829), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Rab regulation of trafficking | 1 |
| Vesicle-mediated transport | 1 |
| Membrane Trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| intracellular protein localization | 1 |
| protein transport | 1 |
| intracellular transport | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| GTPase binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
856 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBC1D13 | SPOUT1 | Q5T280 | 931 |
| TBC1D13 | KYAT1 | Q16773 | 901 |
| TBC1D13 | ENDOG | Q14249 | 838 |
| TBC1D13 | TBC1D19 | Q8N5T2 | 641 |
| TBC1D13 | TBC1D10A | Q9BXI6 | 629 |
| TBC1D13 | TBC1D21 | Q8IYX1 | 626 |
| TBC1D13 | TBC1D10C | Q8IV04 | 618 |
| TBC1D13 | TBC1D10B | Q4KMP7 | 584 |
| TBC1D13 | TBC1D24 | Q9ULP9 | 551 |
| TBC1D13 | TBC1D30 | Q9Y2I9 | 544 |
| TBC1D13 | SGSM3 | Q96HU1 | 541 |
| TBC1D13 | TBC1D2B | Q9UPU7 | 514 |
| TBC1D13 | TBC1D1 | Q86TI0 | 506 |
| TBC1D13 | TBC1D8 | O95759 | 506 |
| TBC1D13 | TBC1D14 | Q9P2M4 | 506 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF618 | TBC1D13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARHGEF5 | TBC1D13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLIN3 | TBC1D13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEPSIN | TBC1D13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPDYE4 | TBC1D13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VPS35 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| HRAS | IGHV1-45 | psi-mi:“MI:0914”(association) | 0.350 |
| TBC1D13 | ZNF618 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARHGEF5 | TBC1D13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBC1D13 | ARHGEF5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBC1D13 | PLIN3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBC1D13 | TEPSIN | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBC1D13 | SPDYE4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): TBC1D13 (Two-hybrid), TBC1D13 (Two-hybrid), ZNF618 (Two-hybrid), ENTHD2 (Two-hybrid), SPDYE4 (Two-hybrid), TBC1D13 (Proximity Label-MS), TBC1D13 (Co-fractionation), TBC1D13 (Co-fractionation), ARMC1 (Co-fractionation), TBC1D13 (Affinity Capture-MS), TBC1D13 (Positive Genetic), TBC1D13 (Proximity Label-MS), TBC1D13 (Proximity Label-MS), TBC1D13 (Proximity Label-MS), TBC1D13 (Proximity Label-MS)
ESM2 similar proteins: A0A0G2QC33, A6H7I8, F1N9S8, O60447, O70566, O73787, O88597, O95453, P58854, P69341, P97366, Q01061, Q01064, Q01065, Q01066, Q0J035, Q14457, Q2T9Q1, Q3U4G0, Q4A1L3, Q4A1L4, Q4A1L5, Q5CD77, Q5E9S8, Q5F361, Q5R878, Q5RC51, Q5ZKS6, Q61143, Q64395, Q69ZT9, Q6DG88, Q6GP52, Q80YV4, Q8BGE6, Q8BM85, Q8CGA2, Q8R3D1, Q8TEA7, Q8UUU2
Diamond homologs: Q54TA5, Q8R3D1, Q9NVG8, Q9URY3, A1A5B6, O43147, P09379, P48365, Q28CB1, Q2NKQ1, Q3MII6, Q6BU76, Q6FWI1, Q80U12, Q8BPQ7, Q8BYH7, Q8TBP0, Q8TC07, Q9CXF4, Q9HA65, Q9UUH7, Q95LL3, Q9NU19, O59737, Q08484, Q54VM3, Q8R5A6, Q8WUA7, Q95KI1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1856 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:128787373:GCCG:G | donor_gain | 1.0000 |
| 9:128787375:CGGT:C | donor_loss | 1.0000 |
| 9:128787376:GGTA:G | donor_loss | 1.0000 |
| 9:128787377:G:GG | donor_gain | 1.0000 |
| 9:128788332:A:AG | acceptor_gain | 1.0000 |
| 9:128788333:G:GA | acceptor_gain | 1.0000 |
| 9:128788333:GA:G | acceptor_gain | 1.0000 |
| 9:128788333:GAA:G | acceptor_gain | 1.0000 |
| 9:128788405:GTG:G | donor_gain | 1.0000 |
| 9:128788406:TG:T | donor_gain | 1.0000 |
| 9:128788406:TGG:T | donor_loss | 1.0000 |
| 9:128788407:GG:G | donor_gain | 1.0000 |
| 9:128788408:G:GC | donor_loss | 1.0000 |
| 9:128788408:G:GG | donor_gain | 1.0000 |
| 9:128788409:T:A | donor_loss | 1.0000 |
| 9:128791589:TGCA:T | acceptor_loss | 1.0000 |
| 9:128791591:CAGGG:C | acceptor_gain | 1.0000 |
| 9:128791592:A:AG | acceptor_gain | 1.0000 |
| 9:128791592:AG:A | acceptor_gain | 1.0000 |
| 9:128791592:AGG:A | acceptor_gain | 1.0000 |
| 9:128791592:AGGGA:A | acceptor_gain | 1.0000 |
| 9:128791593:G:A | acceptor_loss | 1.0000 |
| 9:128791593:G:GG | acceptor_gain | 1.0000 |
| 9:128791593:GG:G | acceptor_gain | 1.0000 |
| 9:128791593:GGG:G | acceptor_gain | 1.0000 |
| 9:128791593:GGGA:G | acceptor_gain | 1.0000 |
| 9:128791593:GGGAG:G | acceptor_gain | 1.0000 |
| 9:128791673:G:GT | donor_gain | 1.0000 |
| 9:128791693:TG:T | donor_loss | 1.0000 |
| 9:128791694:G:GA | donor_loss | 1.0000 |
AlphaMissense
2656 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:128790770:T:A | W45R | 1.000 |
| 9:128790770:T:C | W45R | 1.000 |
| 9:128792496:T:C | L102P | 1.000 |
| 9:128792519:T:A | W110R | 1.000 |
| 9:128792519:T:C | W110R | 1.000 |
| 9:128792521:G:C | W110C | 1.000 |
| 9:128792521:G:T | W110C | 1.000 |
| 9:128792550:T:C | L120P | 1.000 |
| 9:128792567:G:C | D126H | 1.000 |
| 9:128792568:A:C | D126A | 1.000 |
| 9:128792568:A:G | D126G | 1.000 |
| 9:128792568:A:T | D126V | 1.000 |
| 9:128792569:T:A | D126E | 1.000 |
| 9:128792569:T:G | D126E | 1.000 |
| 9:128797057:G:C | R129T | 1.000 |
| 9:128797057:G:T | R129M | 1.000 |
| 9:128797058:G:C | R129S | 1.000 |
| 9:128797058:G:T | R129S | 1.000 |
| 9:128797154:A:C | R161S | 1.000 |
| 9:128797154:A:T | R161S | 1.000 |
| 9:128803344:G:C | R213P | 1.000 |
| 9:128803350:T:C | L215P | 1.000 |
| 9:128803368:T:C | L221P | 1.000 |
| 9:128803385:T:C | Y227H | 1.000 |
| 9:128803393:A:C | Q229H | 1.000 |
| 9:128803393:A:T | Q229H | 1.000 |
| 9:128803394:G:A | G230S | 1.000 |
| 9:128803394:G:C | G230R | 1.000 |
| 9:128803394:G:T | G230C | 1.000 |
| 9:128803395:G:A | G230D | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000065038 (9:128792221 C>T), RS1000283732 (9:128787648 A>C), RS1000321743 (9:128796863 G>A), RS1000358573 (9:128785459 T>C), RS1000381521 (9:128803191 G>C), RS1000454353 (9:128790379 G>A), RS1000713701 (9:128801456 G>A), RS1000765167 (9:128801259 C>A), RS1000882016 (9:128802951 T>A), RS1001124577 (9:128790312 G>A), RS1001176636 (9:128790036 C>G), RS1001432002 (9:128809981 T>C,G), RS1001498387 (9:128796518 T>C), RS1001511189 (9:128786936 G>A,C), RS1001538733 (9:128802212 C>T)
Disease associations
OMIM: gene MIM:616218 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006879_1 | Blood metabolite levels | 1.000000e-09 |
| GCST006879_18 | Blood metabolite levels | 3.000000e-43 |
| GCST006879_19 | Blood metabolite levels | 4.000000e-83 |
| GCST006879_2 | Blood metabolite levels | 2.000000e-12 |
| GCST006879_20 | Blood metabolite levels | 5.000000e-12 |
| GCST006879_21 | Blood metabolite levels | 2.000000e-22 |
| GCST006879_22 | Blood metabolite levels | 2.000000e-20 |
| GCST010242_388 | HDL cholesterol levels | 4.000000e-10 |
| GCST012020_405 | Serum metabolite levels | 1.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | affects phosphorylation | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| nickel sulfate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Dexamethasone | increases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | increases O-linked glycosylation, decreases activity | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.